SOUTH SAN FRANCISCO, Calif., Oct. 8, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (OTCBB:HNAB) today announced that it has entered into a definitive agreement with institutional and other accredited investors to sell, in a private placement, units consisting of shares of its common stock and warrants, which will result in total gross cash proceeds of approximately $12.4 million. Subject to certain customary closing conditions, the closing of the private placement is expected to occur on or before October 9, 2009. Piper Jaffray & Co. served as exclusive placement agent for the transaction.
